Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial-Reference-Cited by-同舟云学术

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

Published:2009-05 Issue:9676 Volume:373 Page:1681-1692
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ellis Paul,Barrett-Lee Peter,Johnson Lindsay,Cameron David,Wardley Andrew,O'Reilly Susan,Verrill Mark,Smith Ian,Yarnold John,Coleman Robert,Earl Helena,Canney Peter,Twelves Chris,Poole Christopher,Bloomfield David,Hopwood Penelope,Johnston Stephen,Dowsett Mitchell,Bartlett John MS,Ellis Ian,Peckitt Clare,Hall Emma,Bliss Judith M

Publisher

Elsevier BV

Subject

General Medicine

Reference42 articles.

1. Polychemotherapy for early breast cancer: an overview of the randomised trials;Lancet,1998

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

3. Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer;Henderson;J Clin Oncol,2003

4. Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28;Mamounas;J Clin Oncol,2005

5. Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres;Dowsett;J Pathol,2003

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The budget impact of utilizing the Oncotype DX Breast Recurrence Score test from a US healthcare payer perspective;Journal of Medical Economics;2023-08-07

2. Setting new research in the context of previous research: some options;BMJ Evidence-Based Medicine;2023-06-24

3. Associated Factors with Breast Nurses Unplanned Interventions in Patients Treated for an Early Breast Cancer;Breast Care;2023

4. Adverse events connected to breast cancer treatment and their associated decrease in quality of life scores;2022-11-29

5. Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test in Node-Negative Early Breast Cancer;ClinicoEconomics and Outcomes Research;2022-09